Physiomics PLC Director Dealing (8063H)
05 Agosto 2019 - 01:00AM
UK Regulatory
TIDMPYC
RNS Number : 8063H
Physiomics PLC
05 August 2019
2 August 2019
Physiomics plc
("Physiomics") or (the "Company")
Director Dealing
The Company announces that it received notice today that
Christophe Chassagnole, the Company's Chief Operating Officer,
acquired 100,000 ordinary shares of 0.4 pence each in the capital
of the Company ("Ordinary Shares") at 3.38 pence per share.
Following the acquisition, Dr Chassagnole is interested in
517,008 Ordinary Shares representing approximately 0.72% of the
Company's issued share capital.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Strand Hanson Ltd (NOMAD)
Richard Tulloch & James Dance
+44 (0) 20 7409 3494
Hybridan LLP (Broker)
Claire Louise Noyce
+44 (0) 20 3764 2341
Notes to Editor
About Physiomics
Physiomics plc (AIM: PYC) is a provider of technology-based
solutions to predict the effects of cancer treatment regimens for
the biopharma industry. The Company's Virtual Tumour(TM) technology
uses computer modelling to predict the effects of cancer drugs and
treatments to improve the success rate of drug discovery and
development projects while reducing time and cost. The predictive
capability of Physiomics' technologies have been confirmed by over
70 projects, involving over 30 targets and 60 drugs, and has worked
with clients such as Merck KGaA, Merck & Co, Bayer and
Lilly.
Based in Oxford UK, the Company works with clients worldwide to
support their pre-clinical and clinical oncology development
programs. Its team of scientists and computer modelling experts
provide bespoke solutions encompassing data, analytics and
insight.
Physiomics senior management has academic and commercial
expertise, including over 120 years collectively of working in
oncology and/or computational biology and over 120 publications in
peer reviewed journals that have attracted thousands of
citations.
The information contained within this announcement is deemed by
the Company to constitute inside information under the Market Abuse
Regulation (EU) No. 596/2014.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Christophe Chassagnole
-------------------------------------------------------------------- -------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status Director, COO
-------------------------------------------------------------------- -------------------------
b) Initial notification/ Amendment Initial notification
-------------------------------------------------------------------- -------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Physiomics plc
-------------------------------------------------------------------- -------------------------
b) LEI 213800A71DSZ6ABMTQ91
-------------------------------------------------------------------- -------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary share
Identification code
GB00BDR6W943
-------------------------------------------------------------------- -------------------------
b) Nature of the transaction Acquisition of shares
-------------------------------------------------------------------- -------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
3.38p 100,000
----------
-------------------------------------------------------------------- -------------------------
d) Aggregated information
* Aggregated volume 100,000
At 3.38p
* Price
-------------------------------------------------------------------- -------------------------
e) Date of the transaction 02-08-2019
-------------------------------------------------------------------- -------------------------
f) Place of the transaction XLON, AIM
-------------------------------------------------------------------- -------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHPTMATMBJMBRL
(END) Dow Jones Newswires
August 05, 2019 02:00 ET (06:00 GMT)
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024